Preparation method of porphyrin photosensitizer and anticarcinogen diad
The technology of a porphyrin-based photosensitizer and an anticancer drug is applied in the field of preparation of a photosensitizer and an anticancer drug duplex, and can solve the problem of the inability to kill cancer cells in the targeting of the anticancer drug, the reduced anticancer ability, and the toxic and side effects. and other problems, to achieve the effect of improving anti-cancer ability and reducing toxic and side effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0011] Specific embodiment one: the preparation method of porphyrin photosensitizer and anticancer drug dyad in this embodiment is as follows:
[0012] 1. Add 10-100 mg of porphyrin photosensitizer, 2-5 g of anhydrous potassium carbonate and 20-40 ml of N, N-dimethylformamide into a 250 ml two-necked flask, and fix the two-necked flask on a stirrer equipped with iced brine , put into the magnet and stir for 5 to 10 minutes, then drop 1 to 5 ml of chloroacetyl chloride with the dropping funnel within 30 to 40 minutes, continue the reaction for 8 to 10 hours, and then remove the potassium carbonate in the product with a sand core funnel, Use 50-100ml of saturated saline and dichloromethane to separate the liquid, take the lower layer solution of the separatory funnel, and continue to extract the obtained lower layer solution with saturated saline solution for 3-5 times, 100ml each time, and dry it with anhydrous sodium sulfate for 24 After ~48 hours, the solvent was evaporated t...
specific Embodiment approach 2
[0014] Specific embodiment 2: The difference between this embodiment and specific embodiment 1 is that the porphyrin photosensitizer described in step 1 is tetra-p-hydroxyphenylporphyrin. Others are the same as in the first embodiment.
specific Embodiment approach 3
[0015] Embodiment 3: The difference between this embodiment and Embodiment 1 or 2 is that the anticancer drug described in step 2 is 10-hydroxycamptothecin, paclitaxel, doxorubicin, 5-fluorouracil or methotrexate Moan. Others are the same as those in the first or second embodiment.
[0016] The structural formula of 10-hydroxycamptothecin in the present embodiment is as follows:
[0017]
[0018] The structural formula of paclitaxel in the present embodiment is as follows:
[0019]
[0020] The structural formula of doxorubicin in the present embodiment is as follows:
[0021]
[0022] The structural formula of 5-fluorouracil in the present embodiment is as follows:
[0023]
[0024] The structural formula of methotrene in the present embodiment is as follows:
[0025]
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com